Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.
Diabetes Metab Syndr
; 14(4): 303-310, 2020.
Article
in English
| MEDLINE | ID: covidwho-676723
ABSTRACT
BACKGROUND AND AIMS:
High prevalence of diabetes makes it an important comorbidity in patients with COVID-19. We sought to review and analyze the data regarding the association between diabetes and COVID-19, pathophysiology of the disease in diabetes and management of patients with diabetes who develop COVID-19 infection.METHODS:
PubMed database and Google Scholar were searched using the key terms 'COVID-19', 'SARS-CoV-2', 'diabetes', 'antidiabetic therapy' up to April 2, 2020. Full texts of the retrieved articles were accessed.RESULTS:
There is evidence of increased incidence and severity of COVID-19 in patients with diabetes. COVID-19 could have effect on the pathophysiology of diabetes. Blood glucose control is important not only for patients who are infected with COVID-19, but also for those without the disease. Innovations like telemedicine are useful to treat patients with diabetes in today's times.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Comorbidity
/
Coronavirus Infections
/
Diabetes Mellitus
/
Betacoronavirus
Type of study:
Observational study
/
Prognostic study
/
Reviews
Limits:
Animals
/
Humans
Language:
English
Journal:
Diabetes Metab Syndr
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS